Welcome to our dedicated page for 1933 Inds news (Ticker: TGIFF), a resource for investors and traders seeking the latest updates and insights on 1933 Inds stock.
1933 Industries Inc. (TGIFF) operates as a vertically integrated cannabis enterprise, producing premium flower, pre-rolls, and extracts under its AMA and Level X brands. This page aggregates official press releases and verified news about the company’s Nevada operations, product innovations, and market strategies.
Investors and industry observers will find timely updates on earnings reports, cultivation facility upgrades, and regulatory developments. The curated collection serves as a reliable resource for tracking the company’s responses to evolving cannabis market conditions and competitive pressures.
Content spans operational milestones, wholesale partnership announcements, and product line changes – including historical context on the suspended Canna Hemp™ CBD business. All materials maintain factual accuracy focus without speculative commentary.
Bookmark this page for streamlined access to 1933 Industries’ latest communications. Check regularly for updates reflecting the company’s position in Nevada’s dynamic cannabis sector.
1933 Industries (CSE:TGIF)(OTCQB:TGIFF), a cannabis consumer packaged goods company, announced it will not amend its 10% Senior Unsecured Convertible Debentures due September 14, 2021, extending maturity to September 14, 2022. The existing indenture will remain unchanged. The Company operates two subsidiaries, managing cultivation and manufacturing of cannabis products.
1933 Industries owns 91% of Alternative Medicine Association and 100% of Infused MFG. Their product suite includes various cannabis formats aimed at both medical and recreational users.
1933 Industries Inc. (CSE:TGIF, OTCQB:TGIFF) has announced that holders of its 10% Senior Unsecured Convertible Debentures, due September 14, 2021, voted to extend the maturity date to September 14, 2022. This amendment was approved at an extraordinary meeting. The effective date is pending regulatory approval from the Canadian Securities Exchange. 1933 Industries, a vertically-integrated cannabis company, is focused on cultivating and manufacturing consumer cannabis goods through its subsidiaries.
1933 Industries reported strong Q2 2021 financial results, with revenues reaching $3.4 million, a 27% increase from the prior quarter. The company achieved a gross margin of 57%, significantly reducing its net loss by 78% to $1.4 million. Adjusted EBITDA loss improved by 98% year-over-year. Major advancements included streamlining operations and expanding premium cannabis product offerings, as well as completing a private placement raising $5 million. However, the pandemic's impact on tourism has affected Canna Hemp™ sales.
1933 Industries Inc. has scheduled an extraordinary meeting for debentureholders to vote on extending the maturity date of its 10% Senior Unsecured Convertible Debentures from September 14, 2021, to September 14, 2022. The meeting will take place virtually on April 14, 2021, at 10:00 a.m. (PT). A Management Information Circular detailing the proposed amendments has been sent to debentureholders and is available on SEDAR and the company's website. The Board encourages support for the extension, aiming to strengthen the company's financial position and optimize performance.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) has successfully closed a bought deal private placement, raising C$4,955,052 through the sale of 31,820,000 units at C$0.11 each. The offering includes the issuance of warrants with an exercise price of C$0.16 until March 4, 2023. Additionally, $8.2 million of convertible debentures have been converted into shares, improving the company's balance sheet. The financing supports growth strategies and enhances investor confidence in the company’s position in the cannabis sector.
1933 Industries Inc. (CSE: TGIF, OTCQB: TGIFF) has announced a bought deal private placement to raise C$3,500,200 by issuing 31,820,000 units at C$0.11 each. Each unit includes one common share and a warrant exercisable at C$0.16 for 24 months. The funds will support facility expansion and corporate purposes. Closing is expected around March 4, 2021, with an option for underwriters to purchase an additional 13,640,000 units. This financing aims to strengthen the company’s balance sheet and facilitate growth in Nevada's cannabis market.
1933 Industries (CSE:TGIF)(OTCQX:TGIFF) reported its Q4 2020 and annual financial results, revealing revenues of $12 million, a significant decline from $18 million in Fiscal 2019, largely due to the COVID-19 pandemic. The net loss reached $22.2 million, compared to $19.1 million the previous year. With a cash balance of $2.76 million, down from $17.6 million, the company aims for profitability in 2021. New management has shifted focus to improving operations and product offerings, particularly in the Nevada cannabis market.
1933 Industries Inc. announced the grant of 12,050,000 stock options to its directors, officers, consultants, and employees, as part of its stock option plan. These options are exercisable for five years at a price of $0.10 per share and will vest over a three-year period. The company, focused on cannabis consumer goods, maintains control over its operations through subsidiaries, including the Alternative Medicine Association and Infused MFG. With a diverse product portfolio, 1933 Industries aims to provide high-quality cannabis products.
1933 Industries (CSE: TGIF) has established a distribution agreement with CBD Plus to market its Canna Hemp™ wellness products in over 120 retail locations across the Midwest and South U.S. The one-year agreement includes a 45-day trial period, commencing immediately. This partnership aims to enhance Canna Hemp™'s presence in the rapidly growing CBD market, projected to reach $12.4 billion by 2023. 1933 Industries' President, Eugene Ruiz, expressed optimism about the collaboration, emphasizing quality and education in CBD wellness.
1933 Industries Inc. announced the continuation of its private placement financing, initially disclosed on July 17, 2020. This vertically-integrated cannabis company focuses on cultivating and manufacturing cannabis consumer goods across various product formats. It operates through two subsidiaries, managing the entire value chain. The firm holds a 91% stake in the Alternative Medicine Association and 100% of Infused MFG LLC, offering a diverse portfolio of brands and licensing partnerships.